Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience

Overview of attention for article published in Cancer Imaging, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#10 of 683)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 3 X users

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 36 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 1 news story.

Delcath: Peek Of Early Data Of FOCUS Trial Shows Vastly Improved Safety Profile Of Chemosat

Seeking Alpha, 25 Sep 2020

Summary Safety data of early part of FOCUS trial have been publicly disseminated.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.